IN2001DE00791A - - Google Patents

Download PDF

Info

Publication number
IN2001DE00791A
IN2001DE00791A IN791DE2001A IN2001DE00791A IN 2001DE00791 A IN2001DE00791 A IN 2001DE00791A IN 791DE2001 A IN791DE2001 A IN 791DE2001A IN 2001DE00791 A IN2001DE00791 A IN 2001DE00791A
Authority
IN
India
Application number
Inventor
Vincent Fischetti
Lawrence Loomis
Original Assignee
New Horizons Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Horizons Diagnostics Inc filed Critical New Horizons Diagnostics Inc
Publication of IN2001DE00791A publication Critical patent/IN2001DE00791A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IN791DE2001 1999-02-25 1999-02-25 IN2001DE00791A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/257,025 US6017528A (en) 1997-10-31 1999-02-25 Therapeutic treatment of group A streptococcal infections
PCT/US1999/004063 WO2000050069A1 (en) 1999-02-25 1999-02-25 A means for the prophylactic and therapeutic treatment of streptococcal infections

Publications (1)

Publication Number Publication Date
IN2001DE00791A true IN2001DE00791A (en) 2007-05-25

Family

ID=26795447

Family Applications (1)

Application Number Title Priority Date Filing Date
IN791DE2001 IN2001DE00791A (en) 1999-02-25 1999-02-25

Country Status (12)

Country Link
US (1) US6017528A (en)
EP (1) EP1162994A4 (en)
JP (1) JP2002537350A (en)
KR (1) KR20020000217A (en)
AU (1) AU2876799A (en)
BR (1) BR9917152A (en)
CA (1) CA2366712A1 (en)
HK (1) HK1047243A1 (en)
IN (1) IN2001DE00791A (en)
MX (1) MXPA01008701A (en)
NZ (1) NZ514260A (en)
WO (1) WO2000050069A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406692B1 (en) 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US6277399B1 (en) * 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6248324B1 (en) 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6335012B1 (en) 1997-10-31 2002-01-01 Vincent Fischetti Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6326002B1 (en) 1997-10-31 2001-12-04 New Horizons Diagnostics Corporation Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract
US20030129147A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US20030082110A1 (en) * 1997-10-31 2003-05-01 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6428784B1 (en) * 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6399098B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corp Composition for treating dental caries caused by streptococcus mutans
US6399097B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corporation Composition for treatment of a bacterial infection of the digestive tract
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US6432444B1 (en) * 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6752988B1 (en) * 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US20020136712A1 (en) * 1997-10-31 2002-09-26 Fischetti Vincent Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
US20020127215A1 (en) * 1999-09-14 2002-09-12 Lawrence Loomis Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
US7063837B2 (en) * 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
AU2001259205A1 (en) * 2000-04-28 2001-11-12 New Horizons Diagnostic Corporation The use of bacterial phage associated lysing enzymes for treating various illnesses
US6608187B2 (en) 2000-05-23 2003-08-19 The Rockefeller University C1 bacteriophage lytic system
US6395504B1 (en) 2000-09-01 2002-05-28 New Horizons Diagnostics Corp. Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants
WO2002102405A1 (en) * 2000-11-02 2002-12-27 New Horizons Diagnostics Corporation The use of bacterial phage associated lytic enzymes to prevent food poisoning
US20040213765A1 (en) * 2001-07-13 2004-10-28 Vincent Fischetti Use of bacterial phage associated lytic enzymes to prevent food poisoning
GB0118009D0 (en) * 2001-07-24 2001-09-19 Regma Biotechnologies Ltd Novel preparation
US6759229B2 (en) * 2001-12-18 2004-07-06 President & Fellows Of Harvard College Toxin-phage bacteriocide antibiotic and uses thereof
AU2003273257A1 (en) * 2002-08-29 2004-03-19 The Uab Research Foundation Group b streptococcal phage lysin
US7569223B2 (en) * 2004-03-22 2009-08-04 The Rockefeller University Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
CN107189997A (en) 2011-04-21 2017-09-22 洛克菲勒大学 The streptococcus bacteriophage lysin for detecting and treating for gram-positive bacteria
US9279118B2 (en) 2011-10-05 2016-03-08 The Rockefeller University Dimeric bacteriophage lysins
EP2849782B1 (en) 2012-05-09 2020-03-18 Contrafect Corporation Bacteriophage lysin and antibiotic combinations against gram positive bacteria
CA2872911C (en) 2012-05-09 2023-10-03 Contrafect Corporation Biofilm prevention, disruption and treatment with bacteriophage lysin
KR101723466B1 (en) * 2015-10-08 2017-04-06 주식회사 인트론바이오테크놀로지 Novel Streptococcus iniae bacteriophage Str-INP-1 and its use for preventing proliferation of Streptococcus iniae
US10851401B2 (en) 2016-05-12 2020-12-01 Contrafect Corporation Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides
US11064730B2 (en) 2016-07-11 2021-07-20 Philip Morris Products S.A. Hydrophobic capsule
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852424A (en) * 1957-07-26 1974-12-03 Ciba Geigy Corp Purified ferrimycin and process for obtaining same
CA1301645C (en) * 1986-10-08 1992-05-26 David Bernstein Method for exposing group a streptococcal antigens and an improved diagnostictest for the identification of group a streptococci
US5997862A (en) * 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections

Also Published As

Publication number Publication date
US6017528A (en) 2000-01-25
CA2366712A1 (en) 2000-08-31
HK1047243A1 (en) 2003-02-14
AU2876799A (en) 2000-09-14
EP1162994A1 (en) 2001-12-19
WO2000050069A1 (en) 2000-08-31
MXPA01008701A (en) 2003-06-24
EP1162994A4 (en) 2004-12-29
BR9917152A (en) 2002-11-26
KR20020000217A (en) 2002-01-05
JP2002537350A (en) 2002-11-05
NZ514260A (en) 2003-02-28

Similar Documents

Publication Publication Date Title
BE2018C020I2 (en)
BE2016C007I2 (en)
BE2015C057I2 (en)
BE2015C018I2 (en)
BE2014C017I2 (en)
BE2013C051I2 (en)
BE2013C020I2 (en)
BE2013C015I2 (en)
BE2013C001I2 (en)
BE2012C036I2 (en)
BE2011C004I2 (en)
BE2010C011I2 (en)
BE2008C046I2 (en)
BE1025464I2 (en)
BRPI0017527B8 (en)
BE2008C047I2 (en)
BRPI0001672A2 (en)
BRPI0001542A2 (en)
BRPI0012675B8 (en)
BRPI0017522A2 (en)
BRMU7902607U2 (en)
CN3097656S (en)
AU2000269752A8 (en)
CN3097870S (en)
AUPP125099A0 (en)